Expression and function of protein kinase CK2 in Hodgkin lymphoma

A Visentin - 2019 - research.unipd.it
Hodgkin lymphoma (HL) is a lymphoid tissue neoplasia accounting for almost 0.6% of all
cancers. The neoplastic cells of Hodgkin and Reed-Sternberg cells (HRS) represent less …

[PDF][PDF] Iranian Journal of Blood & Cancer

M Mirzaei, M Nasiri, M Karimi - IRANIAN JOURNAL OF BLOOD AND CANCER - ijbc.ir
Background: Acute lymphoblastic leukemia (ALL), the most common childhood cancer with
a peak incidence in children from 2-5 years old, might be associated with poor prognosis …

Die Bedeutung phosphorylisierter Signaltransduktionsproteine in der akuten pädiatrischen lymphoblastischen Leukämie

H Kunze - 2016 - oparu.uni-ulm.de
Die akute lymphoblastische Leukämie (ALL) ist mit 30, 6% eine der häufigsten malignen
Erkrankung im Kindes-und Jugendalter. Auch wenn mit den gängigen internationalen …

Targeting of hyperactivated mTOR signaling in high-risk acute lymphoblastic leukemia as a novel treatment strategy

MN Hasan - 2016 - oparu.uni-ulm.de
Although intensification of chemotherapy regimens have improved the outcome of patients
suffering from acute lymphoblastic leukemia (ALL) achieving cure rates of above 80%, about …

A Case-Only Genome-wide Association Study of Gender-and Age-specific Risk Markers for Childhood Leukemia

SK Singh - 2015 - digitalcommons.fiu.edu
Males and age group 1 to 5 years show a much higher risk for childhood acute
lymphoblastic leukemia (ALL). We performed a case-only genome-wide association study …

Determining the prognostic significance of PI3K/Akt/mTOR and JAK/STAT5 signaling pathways in pediatric acute lymphoblastic leukemia using single-cell analysis

ML Oliveira - 2015 - repositorio.ul.pt
Acute lymphoblastic leukemia (ALL) is the most frequent childhood malignancy and it is
characterized by the accumulation of immature lymphoid cells within the bone marrow and …

[图书][B] Preclinical development of a non-immunosuppressive FTY720 derivative OSU-2S for chronic lymphocytic leukemia and other B-cell malignancies

R Mani - 2014 - search.proquest.com
Chemotherapeutics remains a choice of treatment for several malignant diseases. However,
selective cytotoxicity against cancer cells without compromising their normal counterparts …

[PDF][PDF] Blood Disorders & Transfusion

MM Taalab, IM Fawzy, EF Goda, EMA Salam - 2014 - academia.edu
Journal of Page 1 Open Access Taalab et al., J Blood Disorders Transf 2014, 5:7 DOI:
10.4172/2155-9864.1000220 Open Access Volume 5 • Issue 7 • 1000220 J Blood Disorders …